Theravance Biopharma
(NASDAQ:TBPH)
$9.425
-0.035[-0.37%]
Last update: 11:25AM Get Real Time Here
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Theravance Biopharma Inc
Sector
Health Care
Industry
Pharmaceuticals
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, develo...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
TBPH
AVIR

FAQ

Q

How do I buy Theravance Biopharma (TBPH) stock?

A

You can purchase shares of Theravance Biopharma (NASDAQ: TBPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Theravance Biopharma's (TBPH) competitors?

Q

What is the target price for Theravance Biopharma (TBPH) stock?

A

The latest price target for Theravance Biopharma (NASDAQ: TBPH) was reported by BTIG on Friday, April 12, 2024. The analyst firm set a price target for 21.00 expecting TBPH to rise to within 12 months (a possible 121.99% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Theravance Biopharma (TBPH)?

A

The stock price for Theravance Biopharma (NASDAQ: TBPH) is $9.46 last updated April 22, 2024 at 4:00 PM EDT.

Q

Does Theravance Biopharma (TBPH) pay a dividend?

A

There are no upcoming dividends for Theravance Biopharma.

Q

When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?

A

Theravance Biopharma’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is Theravance Biopharma (TBPH) going to split?

A

There is no upcoming split for Theravance Biopharma.

Q

What sector and industry does Theravance Biopharma (TBPH) operate in?

A

Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch